Tampere University of Technology

TUTCRIS Research Portal

Research group: Molecular Signaling Lab

Research unit: Research Group

  1. 2020
  2. Published

    Anticancer activity of THMPP: Downregulation of PI3K/ S6K1 in breast cancer cell line

    Palanivel, S., Murugesan, A., Yli-Harja, O. & Kandhavelu, M., 1 Apr 2020, In : Saudi Pharmaceutical Journal. 28, 4, p. 495-503 9 p.

    Research output: Contribution to journalArticleScientificpeer-review

  3. Published

    Glioblastoma Multiforme Stem Cell Cycle Arrest by Alkylaminophenol Through the Modulation of EGFR and CSC Signaling Pathways

    Doan, P., Musa, A., Murugesan, A., Sipilä, V., Candeias, N. R., Emmert-Streib, F., Ruusuvuori, P., Granberg, K., Yli-Harja, O. & Kandhavelu, M., 10 Mar 2020, In : Cells. 9, 3, 21 p., 681.

    Research output: Contribution to journalArticleScientificpeer-review

  4. Published

    Alkylamino Phenol Derivative Induces Apoptosis by Inhibiting EGFR Signaling Pathway in Breast Cancer Cells

    Palanivel, S., Yli-Harja, O. & Kandhavelu, M., 2020, In : Anti-Cancer Agents in Medicinal Chemistry. 20, 7, p. 809 - 819 11 p.

    Research output: Contribution to journalArticleScientificpeer-review

  5. 2019
  6. Published

    Battling Glioblastoma: A Novel Tyrosine Kinase Inhibitor with Multi-Dimensional Anti-Tumor Effect (Running Title: Cancer Cells Death Signalling Activation)

    Viswanathan, A., Musa, A., Murugesan, A., Vale, J. R., Afonso, C. A. M., Konda Mani, S., Yli-Harja, O., Candeias, N. R. & Kandhavelu, M., 12 Dec 2019, In : Cells. 8, 12, 18 p., 1624.

    Research output: Contribution to journalArticleScientificpeer-review

  7. Published

    Synthesis and preclinical validation of novel P2Y1 receptor ligands as a potent anti-prostate cancer agent

    Le, H. T. T., Rimpilainen, T., Konda Mani, S., Murugesan, A., Yli-Harja, O., Candeias, N. R. & Kandhavelu, M., 12 Dec 2019, In : Scientific Reports. 9, 18938.

    Research output: Contribution to journalArticleScientificpeer-review

  8. Published

    In vitro anti-glioblastoma activity of L-valine derived boroxazolidones

    Viswanathan, A., Sebastianelli, G., Brown, K., Raunio, J., Sipilä, V., Yli-Harja, O., Candeias, N. R. & Kandhavelu, M., 5 Jul 2019, In : European Journal of Pharmacology. 854, p. 194-200 7 p.

    Research output: Contribution to journalArticleScientificpeer-review

  9. Published

    2-(2-(2,4-dioxopentan-3-ylidene)hydrazineyl)benzonitrile as novel inhibitor of receptor tyrosine kinase and PI3K/AKT/mTOR signaling pathway in glioblastoma

    Viswanathan, A., Kute, D., Musa, A., Mani, S. K., Sipilä, V., Emmert-Streib, F., Zubkov, F. I., Gurbanov, A. V., Yli-Harja, O. & Kandhavelu, M., 15 Mar 2019, In : European Journal of Medicinal Chemistry. 166, p. 291 - 303

    Research output: Contribution to journalArticleScientificpeer-review

  10. Published

    Alkylaminophenol induces G1/S phase cell cycle arrest in glioblastoma cells through p53 and cyclin-dependent kinase signaling pathway

    Doan, P., Musa, A., Candeias, N. R., Emmert-Streib, F., Yli-Harja, O. & Kandhavelu, M., 2019, In : FRONTIERS IN PHARMACOLOGY. 10, APR, 330.

    Research output: Contribution to journalArticleScientificpeer-review

  11. 2018
  12. Published

    In vitro characterization of alkylaminophenols-induced cell death

    Doan, P., Anufrieva, O., Yli-Harja, O. & Kandhavelu, M., Feb 2018, In : European Journal of Pharmacology. 820, p. 229-234 6 p.

    Research output: Contribution to journalArticleScientificpeer-review

  13. Published

    GPR17 is a novel target for personalized medicine for glioblastoma

    Doan, P., Musa, A., Nguyen, T., Saravanan, K. M., Sipilä, V., Emmert-Streib, F., Yli-Harja, O. & Kandhavelu, M., 2018, The 4th Annual Finnish Symposium on Brain Tumors, FIBTRA: Vanajanlinna, Hämeenlinna, 29-30 November 2018.

    Research output: Chapter in Book/Report/Conference proceedingConference contributionScientificpeer-review

Previous 1 2 3 4 Next

ID: 10548573